SCHEMBL6290650

SCHEMBL6290650

CCOC(=O)c1cnc2c(c(-c3ccccc3)nn2C)c1NCS(=O)(=O)c1ccc(F)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.49
POLB P06746 1/20 0.49
PKM P14618 1/20 0.49
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
PDE4B Q07343 2/20 0.43
ADORA1 P30542 1/20 0.41
CA12 O43570 1/20 0.41
CA9 Q16790 1/20 0.41
SMN1; SMN2 Q16637 6/20 0.41
ALDH1A1 P00352 6/20 0.41
MAPT P10636 5/20 0.41
MAPK1 P28482 1/20 0.41
ATM Q13315 1/20 0.41
KDM4E B2RXH2 4/20 0.41
TSHR P16473 1/20 0.41
HSD17B10 Q99714 2/20 0.41
ALOX15 P16050 1/20 0.41
MMP1 P03956 1/20 0.41
MMP9 P14780 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6289510 0.91 PDE4B (0.48) LMNAPOLBPKMMEN1KMT2A
SCHEMBL6290687 0.88 LMNA (0.56) LMNAPOLBPKMKMT2APDE4B
SCHEMBL6293912 0.82 NR3C1 (0.50) LMNAPOLBPKMMEN1KMT2A
SCHEMBL6290787 0.81 POLB (0.47) LMNAPOLBPKMKMT2APDE4B
SCHEMBL6290772 0.81 MEN1 (0.55) LMNAPOLBPKMMEN1KMT2A
SCHEMBL6290652 0.81 MMP1 (0.57) LMNAPOLBPKMMEN1KMT2A
SCHEMBL6293214 0.80 MMP1 (0.47) LMNAPOLBPKMMEN1KMT2A
SCHEMBL6289966 0.79 LMNA (0.43) LMNAPOLBPKMPDE4BCA9
SCHEMBL6290579 0.79 MMP1 (0.53) LMNAPOLBPKMPDE4BMMP1
SCHEMBL6290603 0.77 PDE4B (0.47) LMNAPOLBPKMPDE4BADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6946473-B2 Preparation and use of acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors WYETH HOLDINGS CORPORATION (US) 2005-09-20 US disclosed
US-20030208066-A1 Preparation and use of acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors AMERICAN CYANAMID COMPANY 2003-11-06 US disclosed
EP-1279674-A2 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors American Cyanamid Company (US) 2003-01-29 EP disclosed
EP-1157024-B1 ACETYLENIC ORTHO-SULFONAMIDO AND PHOSPHINIC ACID AMIDO BICYCLIC HETEROARYL HYDROXAMIC ACIDS AS TACE INHIBITORS AMERICAN CYANAMID CO (US) 2002-11-06 EP disclosed
EP-1157024-A1 ACETYLENIC ORTHO-SULFONAMIDO AND PHOSPHINIC ACID AMIDO BICYCLIC HETEROARYL HYDROXAMIC ACIDS AS TACE INHIBITORS American Cyanamid Company (US) 2001-11-28 EP disclosed
WO-2000044749-A1 ACETYLENIC ORTHO-SULFONAMIDO AND PHOSPHINIC ACID AMIDO BICYCLIC HETEROARYL HYDROXAMIC ACIDS AS TACE INHIBITORS AMERICAN CYANAMID COMPANY (US) 2000-08-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030208066-A1 Preparation and use of acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors SI, TNF, PTDSS1 LMNA 2997/4885POLB 971/4885PKM 3507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.